Majdi et al. reported that the necroptosis pathway was activated during nonalcoholic fatty liver disease, and inhibition of RIPK1 ameliorated the characteristics of non-alcoholic steatohepatitis in high fat diet fed mice [100]. This evidence concerns the gene RIPK1 and metabolic dysfunction-associated steatotic liver disease.